angiotensin ii has been researched along with Myocardial Ischemia in 126 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 55 (43.65) | 18.2507 |
2000's | 55 (43.65) | 29.6817 |
2010's | 13 (10.32) | 24.3611 |
2020's | 3 (2.38) | 2.80 |
Authors | Studies |
---|---|
Cervantes-Pérez, LG; Del Valle-Mondragón, L; Ibarra-Lara, L; Pastelín-Hernández, G; Sánchez-Aguilar, M; Sánchez-Mendoza, A; Soria-Castro, E | 1 |
Chuprun, JK; Coleman, R; Eguchi, A; Gao, E; Gresham, K; Ibetti, J; Koch, WJ | 1 |
Cambrón-Mora, D; Garcia-Garduño, TC; Padilla-Gutierrez, JR; Valle, Y | 1 |
Liu, G; Yang, C; Yang, H; Yang, P; Yang, S; Zhao, D; Zheng, H | 1 |
Benedict, C; Cheng, Z; Cimini, M; de Lucia, C; Garikipati, VNS; Goukassian, DA; Kishore, R; Koch, WJ; Lucchese, AM; Roy, R; Truongcao, MM; Wang, C | 1 |
Almeida-Coelho, J; Castro-Ferreira, R; Ferreira-Martins, J; Fontes-Carvalho, R; Ladeiras-Lopes, R; Leite-Moreira, AF; Leite-Moreira, AM; Neiva-Sousa, M; Neves, JS | 1 |
De Mello, WC | 3 |
El-Bassossy, HM; Watson, ML | 1 |
Ahmad, S; Deal, D; Dell'Italia, LJ; Ferrario, CM; Groban, L; Kon, ND; Nagata, S; Simington, SW; Varagic, J; VonCannon, JL; Wang, H | 1 |
Chen, P; Li, X; Luo, J; Patterson, AJ; Xue, Q; Zhang, G | 1 |
Alitalo, K; Andersson, LC; Bry, M; Hassinen, IE; Helkamaa, T; Jeltsch, M; Karpanen, T; Kivelä, R; Leskinen, H; Liimatta, E; Merentie, M; Mervaala, E; Ollila, HM; Oresic, M; Paavonen, K; Seppänen-Laakso, T; Ylä-Herttuala, S | 1 |
Curl, CL; Delbridge, LM; Huggins, CE; McLennan, PL; Patel, R; Pedrazzini, T; Pepe, S; Theiss, ML | 1 |
Curtis, MJ; Stables, CL | 1 |
Chen, Q; Dimitrijevic, I; Edvinsson, L; Edvinsson, ML; Kimblad, PO; Malmsjö, M | 1 |
Alenina, N; Bader, M; Dietz, R; Erdmann, B; Geier, C; Ghadge, SK; Morano, I; Morano, RD; Ozcelik, C; Panek, AN; Perrot, A; Popova, E; Posch, MG | 1 |
Chaudhary, AK; Ely, D; Gopinathannair, R; Martins, JB; Xing, D; Zheng, W | 1 |
Alhenc-Gelas, F; Bouby, N; Bruneval, P; Colucci, J; Griol-Charhbili, V; Krege, JH; Mandet, C; Messadi, E; Richer, C; Smithies, O; Vincent, MP | 1 |
Chan, NY; Hashikawa-Hobara, N; Levi, R | 1 |
Gao, L; Lazartigues, E; Xiao, L; Zucker, IH | 1 |
Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Koibuchi, N; Nako, H; Ogawa, H; Toyama, K; Yamamoto, E; Yasuda, O | 1 |
Collier, P; McDonald, KM | 1 |
Koyama, M; Levi, R; Mackins, CJ; Seyedi, N | 1 |
Alberts, G; Boomsma, F; de Zeeuw, S; Duncker, DJ; Lameris, TW; van den Meiracker, AH; Verdouw, PD | 1 |
Ecarnot-Laubriet, A; Oudot, A; Rochette, L; Vergely, C | 2 |
Abramenko, TV; Garats, IE; Kondakova, NM; Kost, OA; Miagkova, MA; Nikol'skaia, II; Pogozheva, AV | 1 |
Allen, DG; Xiao, XH | 1 |
Nygren, E; Wang, QD | 1 |
Bøtker, HE; Grove, E; Kimose, HH; Lund, S; Nielsen, TT; Randsbaek, F; Schmitz, O | 1 |
Díez, J; Fortuño, MA; González, A; López, B; López, N; Querejeta, R; Ravassa, S | 1 |
Aikawa, J; Ebine, K; Fukazawa, M; Ishikawa, M; Kubota, T; Moroi, M; Namiki, A; Yamaguchi, T | 1 |
Kiselev, IP; Kost, OA; Kostrikin, DS; Miagkova, MA; Nikol'skaia, II; Panchenko, ON; Pogozheva, AV; Stanislav, ML; Valuev, DI | 1 |
Levi, R; Mackins, CJ; Reid, AC; Seyedi, N; Silver, RB | 1 |
Drexler, H; Fuchs, M; Grote, K; Hilfiker, A; Hilfiker-Kleiner, D; Kaminska, A; Kaminski, K; Kiian, I; Klein, G; Podewski, E; Wollert, KC | 1 |
Gallagher, G; Huang, Y; Hunyor, SN; Ikeda, Y; Jiang, L; Kawaguchi, O; Shirota, K; Yuasa, T; Zeng, B; Zheng, X | 1 |
Dor, V | 1 |
Doi, K; Francis, GS; Fukamachi, K; Hail, MD; Hoercher, KJ; McCarthy, PM; Ootaki, Y; Schenk, S; Starling, RC; Young, JB | 1 |
Mehta, JL | 1 |
Jaffe, IZ; Mendelsohn, ME | 1 |
du Toit, EF; Lochner, A; Nabben, M | 1 |
Díez, J; Fortuño, MA; López, N | 1 |
Siragy, HM; Webb, RL; Xue, C | 1 |
Alenina, N; Almeida, AP; Bader, M; Castro, CH; Ferreira, AJ; Santos, RA | 1 |
Danser, AH; Krop, M; van Esch, JH | 1 |
Dilsizian, V; Eckelman, WC; Jagoda, EM; Loredo, ML; Shirani, J | 1 |
Figtree, G; Rasmussen, HH | 1 |
Felder, RB; Kang, YM; Weiss, RM; Xue, B; Zhang, ZH | 1 |
Haudenschild, CC; Jacobs, AK; Landau, C | 1 |
Hartman, JC | 1 |
Cohen, MV; Downey, JM; Liu, Y; Tsuchida, A | 1 |
Bartels, GL; de Leeuw, PW; Kruijssen, HA; Remme, WJ; von Schelven, D | 1 |
Xu, S; Zhang, Y | 1 |
Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Saito, H; Tohse, N; Yokoshiki, H | 1 |
Gohlke, P; Linz, W; Schölkens, BA; Unger, T; Wiemer, G | 1 |
Botarelli, M; Corsico, N; Martelli, EA; Mattera, GG; Tobia, P; Vesci, L | 1 |
Akioka, K; Kim, S; Omura, T; Takeuchi, K; Tani, T; Teragaki, M; Toda, I; Yamagishi, H; Yanagi, S; Yoshiyama, M | 1 |
Heitsch, H; Linz, W; Schölkens, BA; Wagner, A; Wiemer, G | 1 |
Ishigaki, H; Katoh, A; Nakagawa, M; Oikawa, Y; Sakuma, M; Shirato, K; Takishima, T | 1 |
Bootsma, M; de Leeuw, PW; Kruyssen, DA; Look, MP; Remme, WJ | 1 |
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Richard, V | 1 |
Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM | 1 |
Brunner, F | 1 |
Campa, PP | 1 |
Kass, DA; Recchia, FA; Saeki, A; Tunin, RS | 1 |
Bethell, HW; Grace, AA; Metcalfe, JC; Vandenberg, JI; Weissberg, PL | 1 |
Hirayama, Y; Ibukiyama, C; Iga, K; Ishii, T; Kiyomi, S; Nagai, Y; Ogawa, T; Takata, Y | 1 |
Cleutjens, JP; Sun, Y; Weber, KT | 1 |
Ferrier, GR; Howlett, SE; Thomas, GP | 1 |
Brunner, F; Kukovetz, WR | 1 |
Swales, JD | 1 |
Bauer, B; Bauer, WR; Ertl, G; Hu, K | 1 |
Ikram, H | 1 |
Apstein, CS; Eberli, FR; Libonati, JR; Sesselberg, HW | 1 |
Hampton, T; Li, J; Morgan, JP; Simons, M | 1 |
Buxton, B; Casley, D; Chai, SY; Froomes, P; Liu, JJ; Mendelsohn, FA; Murone, C; Zhuo, JL | 1 |
Ding, YA; Lee, YM; Peng, YY; Yen, MH | 1 |
Lüscher, TF; Ruschitzka, FT | 1 |
Mertes, PM | 1 |
Breithardt, G; Brisse, B; Deng, MC; Erren, M; Khurana, C; Scheld, HH | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Rossoni, G | 1 |
Drexler, H; Hornig, B | 1 |
Frolkis, I; Gurevitch, J; Keren, G; Kramer, A; Locker, C; Matsa, M; Mohr, R; Paz, Y | 1 |
Bartels, GL; Kruijssen, DA; Remme, WJ; Van Den Heuvel, AF; van der Ent, M; van Veldhuisen, DJ | 1 |
Barry, WH; Boston, DR; Koyama, T; Rodriguez-Larrain, J; Su, Z; Zou, A | 1 |
Clanachan, AS; Ford, WR; Jugdutt, BI; Lopaschuk, GD; Schulz, R | 1 |
Miagkova, MA; Pogozheva, AV; Rozanova, IA; Savitskaia, IuA | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Polvani, GL; Rossoni, G | 1 |
Remme, WJ | 1 |
Bauters, C; Bertrand, ME; Van Belle, E | 1 |
Pepine, CJ | 1 |
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
Sharma, A; Singh, M | 2 |
Lerman, LO; Ritman, EL; Rumberger, JA; Schmermund, A | 1 |
Foy, CA; Grant, PJ; Rice, GI | 1 |
Ball, NA; Jalili, T; Takeishi, Y; Walsh, RA | 1 |
Bernareggi, M; Berti, F; De Gennaro Colonna, V; Deghenghi, R; Locatelli, V; Müller, EE; Rossoni, G; Schweiger, F; Torsello, A | 1 |
Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA | 1 |
Marchini, F; Morazzoni, G; Papp, JG; Parratt, JR; Rastegar, MA; Vegh, A | 1 |
Linz, W; Malinski, T; Schölkens, BA; Wiemer, G; Wohlfart, P | 1 |
Fujikawa, H; Hojo, Y; Ikeda, U; Katsuki, T; Mizuno, O; Shimada, K | 1 |
Hatta, E; Levi, R; Maruyama, R; Smith, NC; Yasuda, K | 1 |
Fujikawa, H; Fukazawa, H; Hojo, Y; Ikeda, U; Katsuki, T; Kurosaki, K; Mizuno, O; Shimada, K | 1 |
Aihara, Y; Kanda, T; Kobayashi, I; Kurabayashi, M; Nagai, R; Ono, Z; Sakamaki, T; Sekiguchi, K; Tanaka, T; Toyama, T; Yokoyama, T | 1 |
Berti, F; De Gennaro Colonna, V; Müller, E; Rossoni, G | 1 |
Anversa, P; Di Somma, S; Kajstura, J; Leri, A; Li, B; Liu, Y | 1 |
Ferrier, GR; Howlett, SE; Louch, WE | 1 |
Braunwald, E; Bristow, MR | 1 |
Barthel, H; Gonzàlez, M; Obal, D; Preckel, B; Schlack, W; Thämer, V | 1 |
Akao, M; Horie, M; Kouchi, I; Murakami, T; Otani, H; Sakurai, T; Sasayama, S; Takano, M | 1 |
Beppu, S; Ishikura, F; Kobayashi, H; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
Chistiakov, DA; Minushkina, LO; Savost'ianov, KV; voron'ko, OE | 1 |
Thorin, E | 1 |
Bandinelli, B; Bertolozzi, I; Boddi, M; Cecioni, I; Coppo, M; Maccherini, M; Modesti, PA; Papa, ML; Polidori, G; Serneri, GG; Toscano, T; Vanni, S | 1 |
Clanachan, AS; Ford, WR; Hiley, CR; Jugdutt, BI | 1 |
Rowe, WJ | 1 |
Almeida, AP; Ferreira, AJ; Santos, RA | 1 |
Guo, H; He, H; Jiang, C; Lu, D; Wang, J; Zhou, B | 1 |
Gong, QL; Wang, WW; Yao, T; Zheng, P; Zhu, YC | 1 |
Li, D; Mehta, JL | 1 |
Trochu, JN | 1 |
Asakura, M; Asanuma, H; Funaya, H; Hori, M; Kim, J; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
Bottari, SP; de Gasparo, M; Levens, NR; Wood, JM | 1 |
Fukuzaki, H; Hayashi, T; Monnaka, H; Odake, M; Takeuchi, M; Tomimoto, S; Tsukamoto, T; Yokota, Y | 1 |
21 review(s) available for angiotensin ii and Myocardial Ischemia
Article | Year |
---|---|
RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Neoplasms; Renin; Renin-Angiotensin System | 2021 |
Intracellular angiotensin II disrupts chemical communication and impairs metabolic cooperation between cardiac myocytes.
Topics: Angiotensin II; Animals; Cell Communication; Heart Failure; Humans; Hyperglycemia; Myocardial Ischemia; Myocytes, Cardiac; Renin-Angiotensin System | 2015 |
Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure.
Topics: Angiotensin II; Animals; Cell Size; Heart; Heart Failure; Humans; Mechanoreceptors; Myocardial Ischemia; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ventricular Remodeling | 2011 |
Cardiomyocyte apoptosis in hypertensive cardiomyopathy.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Apoptosis; Arrhythmias, Cardiac; Humans; Hypertension; MAP Kinase Signaling System; Models, Animal; Myocardial Ischemia; Myocytes, Cardiac; Oxidative Stress; Ventricular Remodeling | 2003 |
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; Lipoproteins, LDL; Myocardial Ischemia; Oxidative Stress; Predictive Value of Tests; Receptors, Oxidized LDL; Risk Factors; Scavenger Receptors, Class E; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction | 2004 |
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular System; Endothelium, Vascular; Humans; Hypertension; Hypertrophy, Left Ventricular; Kallikrein-Kinin System; Kinins; Molecular Sequence Data; Myocardial Ischemia; Nitric Oxide; Rabbits; Rats; Reperfusion Injury | 1995 |
[The coronary circulation, renin-angiotensin system and ACE inhibition].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Coronary Disease; Humans; Myocardial Ischemia; Renin-Angiotensin System | 1995 |
Structural remodeling of the infarcted rat heart.
Topics: Aldosterone; Angiotensin II; Animals; Collagen; Fibrosis; Humans; Metalloendopeptidases; Myocardial Infarction; Myocardial Ischemia; Myocardium; Rats; Renin-Angiotensin System; Wound Healing | 1996 |
Is there a link between the circulating renin-angiotensin system and coronary disease? A sceptical view.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Vessels; Cohort Studies; Humans; Hypertension; Myocardial Ischemia; Prospective Studies; Rats; Renin; Renin-Angiotensin System | 1996 |
The renin-angiotensin system and coronary vasomotion.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Flow Velocity; Cardiomegaly; Coronary Vessels; Dogs; Humans; Hypoxia; In Vitro Techniques; Myocardial Ischemia; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Swine | 1996 |
The renin-angiotensin-aldosterone system and cardiac ischaemia.
Topics: Angina Pectoris; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Blood Flow Velocity; Coronary Vessels; Dogs; Humans; Myocardial Infarction; Myocardial Ischemia; Rats; Renin-Angiotensin System; Vasoconstriction | 1996 |
Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Endothelin-1; Endothelium, Vascular; Humans; Hypertension; Muscle, Smooth, Vascular; Myocardial Ischemia; Nitric Oxide | 1997 |
Endothelial function and bradykinin in humans.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Coronary Disease; Endothelium, Vascular; Humans; Hypertension; Myocardial Ischemia; Nitric Oxide; Renin-Angiotensin System | 1997 |
Effect of ACE inhibition on neurohormones.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Controlled Clinical Trials as Topic; Humans; Myocardial Infarction; Myocardial Ischemia; Norepinephrine; Peptidyl-Dipeptidase A | 1998 |
[From the angiogenic response to ischemia to the validation of the concept of "therapeutic angiogenesis"].
Topics: Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Endothelial Growth Factors; Humans; Lymphokines; Myocardial Ischemia; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Endothelium, Vascular; Humans; Myocardial Ischemia | 1998 |
Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Coronary Circulation; Humans; Myocardial Ischemia; Myocardium; Receptors, Angiotensin | 1999 |
Interactions among ACE, kinins and NO.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Kinins; Myocardial Ischemia; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Ventricular Remodeling | 1999 |
Ischemic cardiomyopathy and the cellular renin-angiotensin system.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathy, Dilated; Cell Survival; Cells, Cultured; Humans; Myocardial Ischemia; Myocardium; Rats; Renin-Angiotensin System; Sensitivity and Specificity; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2000 |
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor.
Topics: Angiotensin II; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Gene Expression; Humans; Myocardial Ischemia; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha; Up-Regulation | 2002 |
Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cough; Glaucoma; Humans; Hypertension, Renal; Kidney; Muscle, Smooth, Vascular; Myocardial Ischemia; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Reperfusion Injury | 1992 |
5 trial(s) available for angiotensin ii and Myocardial Ischemia
Article | Year |
---|---|
[Change of natural antibody levels in patients with cardiovascular diseases by the use of anti-atherogenic diets with processed soy product foods].
Topics: Adult; Aged; alpha-Macroglobulins; Angiotensin II; Antibodies; Antithrombin III; Cardiovascular Diseases; Cholesterol; Diet Therapy; Dietary Proteins; Female; Food Handling; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Soybean Oil; Soybean Proteins; Thrombin; Triglycerides | 2002 |
Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Autoradiography; Endothelium, Vascular; Hemodynamics; Humans; In Vitro Techniques; Indoles; Mammary Arteries; Middle Aged; Myocardial Ischemia; Peptidyl-Dipeptidase A; Perindopril | 1997 |
[Effect of anti-atherosclerotic diet with polyunsaturated fatty acids omega-3 from linseed oil on dynamics of natural antibodies to bradykinin and angiotensin II in blood serum of patients with cardiovascular diseases].
Topics: Adult; Angiotensin II; Antibodies; Arteriosclerosis; Bradykinin; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Humans; Hyperlipoproteinemias; Hypertension; Linseed Oil; Male; Middle Aged; Myocardial Ischemia | 1998 |
Inhibition of angiotensin converting enzyme cannot prevent increases in angiotensin II production in coronary circulation.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Myocardial Ischemia | 2000 |
Augmented responses of angiotensin I and II in patients with ischemic heart disease: relation to left ventricular function.
Topics: Aged; Angiotensin I; Angiotensin II; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Pilot Projects; Renin-Angiotensin System; Stroke Volume; Sympathetic Nervous System; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
100 other study(ies) available for angiotensin ii and Myocardial Ischemia
Article | Year |
---|---|
Clofibrate improves myocardial ischemia-induced damage through regulation of renin-angiotensin system and favours a pro-vasodilator profile in left ventricle.
Topics: Angiotensin II; Animals; Clofibrate; Fibrosis; Heart Ventricles; Male; Myocardial Ischemia; Myocardium; Nitric Oxide; Oxidative Stress; Peptidyl-Dipeptidase A; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Time Factors | 2020 |
GRK5 is a regulator of fibroblast activation and cardiac fibrosis.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Transdifferentiation; Fibroblasts; Fibrosis; G-Protein-Coupled Receptor Kinase 5; Mice, Knockout; Models, Biological; Myocardial Ischemia; Myocardium; Myofibroblasts; Rats | 2021 |
Atorvastatin Attenuates Metabolic Remodeling in Ischemic Myocardium through the Downregulation of UCP2 Expression.
Topics: Angiotensin II; Animals; Atorvastatin; Coronary Vessels; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Rats; Uncoupling Protein 2 | 2018 |
Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction.
Topics: Angiotensin II; Animals; Antibodies, Neutralizing; Cardiomyopathies; Cell Survival; Cicatrix; Echocardiography; Fibrosis; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Inflammation; Macrophages; Membrane Glycoproteins; Mice; Monocytes; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Regeneration; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Remodeling | 2019 |
The effects of angiotensin II signaling pathway in the systolic response to acute stretch in the normal and ischemic myocardium.
Topics: Angiotensin II; Animals; Blood Pressure; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Protein Kinase C; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Stress, Mechanical; Stress, Physiological | 2013 |
Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Animals; Diet, High-Fat; Electrocardiography; Enzyme Inhibitors; Hemodynamics; Inflammation; Insulin Resistance; Isoproterenol; Male; Myocardial Ischemia; Myocardium; Oxidative Stress; Rats, Wistar; Ultrasonography; Uric Acid; Xanthine Oxidase | 2015 |
Differential expression of the angiotensin-(1-12)/chymase axis in human atrial tissue.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensinogen; Atrial Fibrillation; Chymases; Echocardiography; Female; Gene Expression Regulation, Enzymologic; Heart Atria; Heart Valve Diseases; Humans; Male; Middle Aged; Myocardial Ischemia; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2015 |
Maternal High-Fat Diet Causes a Sex-Dependent Increase in AGTR2 Expression and Cardiac Dysfunction in Adult Male Rat Offspring.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Diet, High-Fat; Female; Fetal Development; Genetic Predisposition to Disease; Heart Diseases; Imidazoles; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sex Characteristics | 2015 |
Intracellular and extracellular renin have opposite effects on the regulation of heart cell volume. Implications for myocardial ischaemia.
Topics: Angiotensin II; Angiotensinogen; Animals; Bumetanide; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Separation; Cell Size; Cricetinae; Diuretics; Extracellular Space; Hypotonic Solutions; Myocardial Ischemia; Myocytes, Cardiac; Ouabain; Patch-Clamp Techniques; Renin; Serine Proteinase Inhibitors; Sodium-Potassium-Exchanging ATPase | 2008 |
Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
Topics: Angiotensin II; Animals; Blood Pressure; Capillaries; Cardiomegaly; Cardiomyopathies; Cell Size; Ceramides; Coronary Vessels; Disease Models, Animal; Heart Rate; Humans; Hypertension; Lipid Metabolism; Mice; Mice, Transgenic; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Neovascularization, Physiologic; Oxidation-Reduction; Promoter Regions, Genetic; Skin; Time Factors; Triglycerides; Up-Regulation; Vascular Endothelial Growth Factor B; Ventricular Function, Left; Ventricular Myosins | 2008 |
Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice.
Topics: Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Dietary Fats, Unsaturated; Disease Models, Animal; Estrogens; Female; Fish Oils; Genetic Predisposition to Disease; Hypertrophy; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Ovariectomy; Reperfusion Injury | 2009 |
Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation.
Topics: Angiotensin II; Animals; Cardiac Pacing, Artificial; Catecholamines; Disease Models, Animal; Electrocardiography; Heart Rate; Male; Mice; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Perfusion; Time Factors; Ventricular Fibrillation | 2009 |
Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease.
Topics: Aged; Angina Pectoris; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Arteries; Blotting, Western; Case-Control Studies; Coronary Artery Bypass; Dose-Response Relationship, Drug; Endothelin-1; Humans; Imidazoles; Immunohistochemistry; Middle Aged; Muscle, Smooth, Vascular; Myocardial Ischemia; Myography; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; Subcutaneous Tissue; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 2009 |
Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload.
Topics: Angiotensin II; Animals; Base Sequence; Calcium; Cardiomegaly; Connective Tissue Growth Factor; DNA Primers; Enzyme Activation; Humans; Isoproterenol; MAP Kinase Kinase 4; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Polymerase Chain Reaction; Pressure; Proto-Oncogene Proteins c-akt; Rats | 2009 |
Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor.
Topics: Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Electrocardiography; Electrophysiologic Techniques, Cardiac; Endocardium; Female; Imidazoles; Infusions, Intravenous; Losartan; Male; Myocardial Ischemia; Myocardium; Purkinje Fibers; Pyridines; Receptor, Angiotensin, Type 2; Signal Transduction; Tachycardia, Ventricular; Time Factors | 2009 |
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.
Topics: Amides; Angiotensin I; Angiotensin II; Animals; Apoptosis; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Fumarates; Heart; Kinins; Lung; Mice; Mice, Mutant Strains; Myocardial Infarction; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Renin; Reperfusion Injury | 2010 |
Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
Topics: Angiotensin II; Animals; Guinea Pigs; Heart; Histamine Agonists; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nerve Endings; Neurons; Nitric Oxide; PC12 Cells; Protein Kinase C; Rats; Receptor, Angiotensin, Type 1; Receptors, Histamine H3; Sodium-Hydrogen Exchangers; Sympathetic Nervous System; Synaptosomes; Tetradecanoylphorbol Acetate | 2012 |
Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Baroreflex; Enzyme Induction; Heart Failure; Humans; Male; Medulla Oblongata; Mice; Mice, Knockout; Myocardial Ischemia; Nerve Tissue Proteins; Nitric Oxide; Norepinephrine; Organ Specificity; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reflex, Abnormal; Sympathetic Nervous System | 2011 |
Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Biphenyl Compounds; Blood Pressure; Blotting, Western; Capillaries; Cells, Cultured; Cyclic N-Oxides; Endothelial Cells; Heart Diseases; Hydralazine; Hypertension; Hypertrophy, Left Ventricular; Immunohistochemistry; Irbesartan; MAP Kinase Kinase Kinase 5; Myocardial Ischemia; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Spin Labels; Superoxides; Tetrazoles; Ultrasonography; Vascular Endothelial Growth Factor A | 2012 |
The role of renin angiotensin system intervention in stage B heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetic Angiopathies; Heart Failure; Humans; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Signal Transduction; Stroke Volume; Ventricular Dysfunction, Left | 2012 |
Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release.
Topics: Angiotensin II; Antihypertensive Agents; Female; Heart Atria; Heart Conduction System; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Sympathetic Nervous System; Synaptosomes; Tetrazoles | 2002 |
Exogenous angiotensin II does not facilitate norepinephrine release in the heart.
Topics: Angiotensin II; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart; Hemodynamics; Infusions, Intra-Arterial; Kinetics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Norepinephrine; Swine; Sympathetic Nervous System | 2002 |
Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Coronary Circulation; Enzyme Activation; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Losartan; Male; Membrane Glycoproteins; Membrane Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; NADPH Dehydrogenase; NADPH Oxidase 2; NADPH Oxidases; Perfusion; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Ventricular Function, Left | 2003 |
The role of endogenous angiotensin II in ischaemia, reperfusion and preconditioning of the isolated rat heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Losartan; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Sprague-Dawley; Sodium-Hydrogen Exchangers | 2003 |
Various inotropic effects of angiotensin II in post-ischaemic rat hearts depending on ischaemic time with possible involvement of protein kinase C.
Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Blood Pressure; Cardiotonic Agents; Heart; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Phenanthridines; Protein Kinase C; Rats; Rats, Sprague-Dawley | 2003 |
Angiotensin II inhibition increases cellular glucose transport during reperfusion but not ischemia in pig hearts.
Topics: Adenosine Triphosphate; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiac Pacing, Artificial; Cell Membrane; Disease Models, Animal; Female; Glucose; Glucose Transporter Type 4; Glycogen; Heart Rate; Infusions, Intravenous; Insulin; Male; Models, Cardiovascular; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Renin; Swine; Systole; Time Factors | 2003 |
Endothelin-1 concentrations in pericardial fluid are more elevated in patients with ischemic heart disease than in patients with nonischemic heart disease.
Topics: Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Growth Substances; Humans; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Pericardial Effusion; Prognosis; Receptors, Tumor Necrosis Factor | 2003 |
[Diagnostic implications of detecting antibodies to angiotensin-converting enzyme and its substrates].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Asthma; Autoantibodies; Bradykinin; Humans; Immunoenzyme Techniques; Myocardial Ischemia; Peptidyl-Dipeptidase A | 2003 |
Coupling of angiotensin II AT1 receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemia.
Topics: Angiotensin II; Animals; Calcium Signaling; Cell Line; Guinea Pigs; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Isoenzymes; Male; Myocardial Ischemia; Nerve Endings; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Pyridinium Compounds; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Sodium; Sodium-Hydrogen Exchangers; Sympathetic Nervous System; Symporters; Synaptosomes | 2004 |
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation.
Topics: Alkaloids; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Benzophenanthridines; Cell Movement; Cells, Cultured; Cysteine-Rich Protein 61; Flavonoids; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Interleukin-6; Leukemia Inhibitory Factor; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myocytes, Smooth Muscle; Naphthalenes; Neovascularization, Physiologic; Norepinephrine; Paracrine Communication; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; RNA, Messenger; Stress, Mechanical; Telmisartan; Tumor Necrosis Factor-alpha | 2004 |
Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Caspase 2; Caspase 3; Caspase 8; Caspases; Chronic Disease; Collagen; Coronary Vessels; Embolism; Extracellular Matrix; Fas Ligand Protein; Female; Heart Failure; Male; Membrane Glycoproteins; Microcirculation; Microspheres; Myocardial Contraction; Myocardial Ischemia; Myocardium; Severity of Illness Index; Sheep; Stroke Volume; Ventricular Remodeling | 2004 |
Left ventricular reconstruction: the aim and the reality after twenty years.
Topics: Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Ventricular Function, Left | 2004 |
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
Topics: Aged; Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Statistics as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2004 |
Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Enzyme Activation; Heart; In Vitro Techniques; Losartan; Male; Myocardial Ischemia; Myocardium; NADPH Oxidases; Peptide Fragments; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reperfusion | 2005 |
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adenoviridae; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Aorta; Cell Line, Transformed; Coronary Vessels; Gene Expression Profiling; Gene Expression Regulation; Genes, Reporter; Genetic Vectors; Humans; Hydrocortisone; Losartan; Mammary Tumor Virus, Mouse; Models, Biological; Muscle, Smooth, Vascular; Myocardial Ischemia; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Spironolactone; Transcription, Genetic; Transduction, Genetic | 2005 |
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
Topics: Angiotensin II; Animals; Blood Glucose; Cardiac Output; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Obesity; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes.
Topics: Aging; Angiotensin II; Animals; Antigens, CD; bcl-Associated Death Protein; Cardiotonic Agents; Carrier Proteins; Cell Death; Cells, Cultured; Cytokine Receptor gp130; Cytokines; DNA-Binding Proteins; Hydrogen Peroxide; Male; Membrane Glycoproteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Ischemia; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor; Trans-Activators | 2005 |
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Calcium Channel Blockers; Cyclic GMP; Drug Therapy, Combination; Gene Expression Regulation; Interleukin-6; Male; Myocardial Ischemia; NF-kappa B; Nitric Oxide; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha | 2006 |
Effects of genetic deletion of angiotensin-(1-7) receptor Mas on cardiac function during ischemia/reperfusion in the isolated perfused mouse heart.
Topics: Angiotensin I; Angiotensin II; Animals; Diastole; Mice; Mice, Knockout; Myocardial Ischemia; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Reperfusion; Systole | 2006 |
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
Topics: Angiotensin II; Angiotensinogen; Animals; Anti-Arrhythmia Agents; Buffers; Captopril; Diabetes Complications; Diabetes Mellitus, Experimental; Diffusion; Free Radical Scavengers; Imidazoles; Kallikreins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Perfusion; Rats; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 90-kDa; Species Specificity; Tetrazoles | 2006 |
Evidence for tissue angiotensin-converting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer technique.
Topics: Angiotensin II; Autoradiography; Chymases; Collagen; Humans; Immunohistochemistry; In Vitro Techniques; Lisinopril; Male; Mast Cells; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Radiopharmaceuticals; Receptor, Angiotensin, Type 1 | 2007 |
"Don't flog the heart!" - development of specific drug therapies for heart failure.
Topics: Angiotensin II; Animals; Disease Models, Animal; Heart Failure; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Receptors, Adrenergic, beta-3; Renin-Angiotensin System; Sodium-Potassium-Exchanging ATPase; Up-Regulation | 2007 |
Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure.
Topics: Action Potentials; Adrenocorticotropic Hormone; Angiotensin II; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Cytokines; Dinoprostone; Disease Models, Animal; Heart Failure; Hypothalamo-Hypophyseal System; Hypothalamus; Inflammation Mediators; Infusions, Parenteral; Interleukin-1beta; Male; Myocardial Ischemia; Norepinephrine; Paraventricular Hypothalamic Nucleus; Pentoxifylline; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Superoxides; Tumor Necrosis Factor-alpha; Ultrasonography | 2008 |
Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia.
Topics: Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Fibroblast Growth Factor 2; Hypertrophy, Left Ventricular; Infusion Pumps, Implantable; Male; Myocardial Ischemia; Neovascularization, Pathologic; Pericardium; Rabbits; Statistics, Nonparametric; Stimulation, Chemical | 1995 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts.
Topics: Angiotensin II; Animals; Enzyme Activation; Female; Hemodynamics; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Protein Kinase C; Rabbits | 1995 |
Acute hemodynamic and neurohumoral profile of dilevalol in hypertensive patients with ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Cardiac Catheterization; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Ischemia; Myocardium; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Renin | 1993 |
Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
Topics: Angiotensin II; Animals; Cardiomegaly; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Renin; Renin-Angiotensin System | 1995 |
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Body Weight; Captopril; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Organ Size; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
Decreased density of endothelin binding sites in adrenal glands but not in aorta, of long term infarcted rats.
Topics: Adrenal Glands; Angiotensin II; Animals; Aorta, Thoracic; Binding Sites; Disease Models, Animal; Endothelins; Male; Myocardial Ischemia; Rats; Time Factors | 1994 |
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Creatine Kinase; Heart; Heart Rate; Heart Ventricles; Indans; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Tetrazoles; Ventricular Pressure | 1994 |
The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Bradykinin; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Female; In Vitro Techniques; Male; Myocardial Ischemia; Nitric Oxide; Nitroarginine; Oligopeptides; Rats; Rats, Wistar; Receptors, Angiotensin | 1993 |
Effects of changes in afterload on regional wall motion in acute ischemic canine heart.
Topics: Angiotensin II; Animals; Coronary Vessels; Dogs; Female; Heart; Male; Myocardial Contraction; Myocardial Ischemia; Nitroprusside; Stroke Volume; Ventricular Pressure | 1993 |
Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans.
Topics: Adult; Aged; Angiotensin II; Cardiac Output; Cardiac Pacing, Artificial; Catecholamines; Coronary Angiography; Coronary Disease; Female; Heart; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardial Ischemia; Neurosecretory Systems; Stroke Volume | 1994 |
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Enalaprilat; Female; Furosemide; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Renin-Angiotensin System; Tetrazoles | 1993 |
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles | 1993 |
Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion.
Topics: Angiotensin II; Animals; Coronary Vessels; Endothelins; Endothelium; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Thrombin; Vasoconstrictor Agents | 1995 |
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion.
Topics: Acute Disease; Angiotensin II; Animals; Blood Vessels; Cardiac Output; Compliance; Coronary Circulation; Disease Models, Animal; Dogs; Female; Hemodynamics; Hypertension; Male; Myocardial Infarction; Myocardial Ischemia; Vascular Resistance | 1996 |
Angiotensin II stimulates sodium-dependent proton extrusion in perfused ferret heart.
Topics: Alkalosis; Amiloride; Angiotensin II; Animals; Bicarbonates; Female; Ferrets; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Perfusion; Pressure; Protons; Sodium; Ventricular Function, Left | 1996 |
The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Female; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium | 1996 |
Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Electric Stimulation; Endocardium; Guinea Pigs; Heart Conduction System; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardial Ischemia; Reperfusion Injury; Tetrazoles | 1996 |
Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Bradykinin Receptor Antagonists; Endothelin Receptor Antagonists; Endothelins; Female; Heart; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1996 |
Effects of low-flow ischemia on the positive inotropic action of angiotensin II in isolated rabbit and rat hearts.
Topics: Angiotensin II; Animals; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Perfusion; Rabbits; Rats; Rats, Wistar; Species Specificity; Stimulation, Chemical; Vasoconstrictor Agents; Ventricular Pressure | 1997 |
Stretch-induced VEGF expression in the heart.
Topics: Angiotensin II; Animals; Antibodies; Catheterization; Diastole; Endothelial Growth Factors; Endothelin Receptor Antagonists; Endothelin-1; Heart; In Vitro Techniques; Lymphokines; Male; Myocardial Ischemia; Myocardium; Peptides, Cyclic; Protein Kinase C; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saralasin; Staurosporine; Transcription, Genetic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1997 |
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR | 1997 |
Cardiac microdialysis.
Topics: Angiotensin II; Animals; Endothelin-1; Extracellular Space; Heart; Hydroxyl Radical; Microdialysis; Myocardial Ischemia; Neuropeptide Y; Norepinephrine | 1998 |
Ischemic versus idiopathic cardiomyopathy: differing neurohumoral profiles despite comparable peak oxygen uptake.
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Epinephrine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Pilot Projects; Receptors, Interleukin-2; Regression Analysis; Renin; Renin-Angiotensin System; Statistics, Nonparametric; Sympathetic Nervous System; T-Lymphocytes | 1997 |
Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antibodies; Coronary Circulation; Endothelium, Vascular; Growth Hormone; Growth Hormone-Releasing Hormone; Growth Substances; Immunization, Passive; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Ventricular Pressure | 1997 |
Effects of an angiotensin II antagonist on ischemic and nonischemic isolated rat hearts.
Topics: Angiotensin II; Animals; Coronary Circulation; Heart; Heart Arrest, Induced; Hemodynamics; Losartan; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Rats; Rats, Wistar | 1998 |
Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Benzeneacetamides; Cardiac Pacing, Artificial; Coronary Circulation; Electrocardiography; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Propanolamines; Sympathomimetics; Ventricular Dysfunction, Left | 1998 |
Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes.
Topics: Angiotensin II; Animals; Calcium; Cyanides; Flow Cytometry; Heart; Myocardial Contraction; Myocardial Ischemia; Myocardium; Rabbits; Sodium; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase | 1998 |
Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function.
Topics: Angiotensin II; Animals; Heart; Ion Transport; Male; Myocardial Contraction; Myocardial Ischemia; Protons; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1998 |
Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Angiotensin II; Animals; Growth Hormone; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oligopeptides; Protective Agents; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Role of angiotensin in cardioprotective effect of ischemic preconditioning.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Creatine Kinase; Female; Heart Rate; Imidazoles; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Pyridines; Rats; Rats, Wistar; Tetrazoles | 1999 |
Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease.
Topics: Aged; Angiotensin II; Case-Control Studies; Coronary Angiography; Coronary Disease; Female; Genotype; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, Angiotensin; Risk | 1999 |
Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated.
Topics: Angiotensin II; Animals; Biological Transport; Enzyme Activation; Guinea Pigs; Hemodynamics; Hypoxia; In Vitro Techniques; Isoenzymes; Male; Myocardial Ischemia; Myocardium; Oxidative Stress; Protein Kinase C; Protein-Tyrosine Kinases; Subcellular Fractions; Tissue Distribution; Type C Phospholipases | 1999 |
Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Creatine Kinase; Growth Hormone; Heart; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley | 1999 |
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors | 1999 |
The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Bradykinin; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Kidney; Lung; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neprilysin; Peptidyl-Dipeptidase A; Phenylalanine | 2000 |
Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
Topics: Aged; Angiotensin II; Chymases; Female; Humans; Imidazoles; Losartan; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Serine Endopeptidases; Tetrazoles | 2000 |
Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Angiotensin II; Atherectomy, Coronary; Coronary Vessels; Endothelin-1; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Stents; Thrombomodulin; Treatment Outcome; von Willebrand Factor | 2000 |
Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antibodies; Area Under Curve; Body Weight; Coronary Vessels; Cytoprotection; Endothelium, Vascular; Growth Hormone; Growth Hormone-Releasing Hormone; Heart Ventricles; Male; Myocardial Ischemia; Myocardial Reperfusion; Oligopeptides; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilation | 1998 |
Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Agents; Colchicine; Creatine Kinase; Female; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Polymyxins; Prazosin; Rats; Rats, Wistar; Reserpine; Tyramine | 2000 |
Losartan improves recovery of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Guinea Pigs; Heart Ventricles; Losartan; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Patch-Clamp Techniques; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2000 |
Congestive heart failure: fifty years of progress.
Topics: Angiotensin II; Apoptosis; Calcium; Cardiomegaly; Cardiomyopathies; Cytokines; Heart Failure; History, 20th Century; Humans; Models, Cardiovascular; Myocardial Contraction; Myocardial Ischemia; Signal Transduction | 2000 |
Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Dogs; Heart; Hemodynamics; Injections, Intravenous; Irbesartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Tetrazoles | 2000 |
Angiotensin II type 1 receptor blockade abolishes specific K(ATP)channel gene expression in rats with myocardial ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Blotting, Western; DNA, Complementary; Lisinopril; Male; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Potassium Channels; Potassium Channels, Inwardly Rectifying; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; RNA, Messenger; Tetrazoles; Time Factors; Up-Regulation | 2000 |
Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Coronary Vessels; DNA; DNA-Binding Proteins; Drosophila Proteins; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Guanine Nucleotide Exchange Factors; Imidazoles; Imidazolidines; Immunoblotting; Janus Kinase 1; Janus Kinase 2; Male; Myocardial Infarction; Myocardial Ischemia; Peptidyl-Dipeptidase A; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Time Factors; Trans-Activators | 2001 |
[Polymorphic markers of endothelial NO-synthase and angiotensin II vascular receptor genes and predisposition to ischemic heart disease].
Topics: Angiotensin II; Genetic Markers; Genetic Predisposition to Disease; Humans; Myocardial Ischemia; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Receptors, Angiotensin | 2000 |
Different contribution of endothelial nitric oxide in the relaxation of human coronary arteries of ischemic and dilated cardiomyopathic hearts.
Topics: Acetylcholine; Adult; Aged; Angiotensin II; Cardiomyopathy, Dilated; Coronary Vessels; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nitric Oxide; Nitroarginine; Substance P; Vasodilation | 2001 |
Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensinogen; Cardiomyopathy, Dilated; Cardiovascular Diseases; Chymases; Endothelin-1; Gene Expression; Gene Expression Regulation; Heart Ventricles; Immunohistochemistry; In Situ Hybridization; Insulin-Like Growth Factor I; Iodine Radioisotopes; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Platelet-Derived Growth Factor; Protein Precursors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Serine Endopeptidases; Ventricular Function, Left | 2001 |
Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.
Topics: Angiotensin II; Animals; Blood Pressure; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Perfusion; Rats; Rats, Sprague-Dawley | 2001 |
Interplanetary travel and permanent injury to normal heart.
Topics: Aerospace Medicine; Angiotensin II; Animals; Astronauts; Catecholamines; Exercise Therapy; Free Radicals; Humans; Magnesium; Magnesium Deficiency; Myocardial Ischemia; Myocardium; Nitric Oxide; Personnel Selection; Physical Endurance; Space Flight; Weightlessness; Weightlessness Countermeasures | 1997 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
[Study on the relation between hypertensive left ventricular hypertrophy in very old people with neurohormonal factors and ventricular arrhythmias].
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Myocardial Ischemia; Renin | 2000 |
[Effect of angiotensin II on potassium channels of ischemic ventricular myocytes of the guinea pig].
Topics: Angiotensin II; Animals; Cells, Cultured; Female; Guinea Pigs; Heart Ventricles; Male; Myocardial Ischemia; Myocytes, Cardiac; Potassium Channels | 2002 |
[Bradykinin and ventricular function].
Topics: Angiotensin II; Blood Pressure; Bradykinin; Humans; Myocardial Ischemia; Ventricular Function; Ventricular Remodeling | 2002 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Coronary Vessels; Dogs; Drug Synergism; Imidazoles; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin; Tetrazoles; Thiazepines; Vasodilation | 2002 |
[Transmitral flow velocity patterns as influenced by preload, afterload and heart rate alterations: pulsed Doppler echocardiographic study].
Topics: Angiotensin II; Blood Flow Velocity; Dextrans; Echocardiography, Doppler; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve; Myocardial Ischemia | 1991 |